Ruane Cunniff's GMED Position Overview
Ruane Cunniff (via Ruane, Cunniff & Goldfarb L.P.) currently holds 6,008 shares of Globus Medical, Inc. (GMED) worth $517,649, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ruane Cunniff has initiated a new position in GMED, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ruane Cunniff's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Ruane Cunniff
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,008 | New Buy | 6,008 | $86.16 |
Ruane Cunniff's Globus Medical Investment FAQs
Ruane Cunniff first purchased Globus Medical, Inc. (GMED) in Q1 2026, acquiring 6,008 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ruane Cunniff has held Globus Medical, Inc. (GMED) for 1 quarters since Q1 2026.
Ruane Cunniff's largest addition to Globus Medical, Inc. (GMED) was in Q1 2026, adding 6,008 shares worth $517,649.
According to the latest 13F filing for Q1 2026, Ruane Cunniff's firm, Ruane, Cunniff & Goldfarb L.P., owns 6,008 shares of Globus Medical, Inc. (GMED), valued at approximately $517,649.
As of the Q1 2026 filing, Globus Medical, Inc. (GMED) represents approximately 0.01% of Ruane Cunniff's publicly disclosed stock portfolio, making it one of their key holdings.
Ruane Cunniff's peak holding in Globus Medical, Inc. (GMED) was 6,008 shares, as reported at the end of Q1 2026.